エクソソーム診断・治療のアジア太平洋市場予測2019-2027

調査会社Inkwood Research社が発行したリサーチレポート(データ管理コード:INKW906134)
◆英語タイトル:ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027
◆発行会社/調査会社:Inkwood Research
◆商品コード:INKW906134
◆発行日:2019年5月13日
◆調査対象地域:アジア太平洋
◆産業分野:医療
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥216,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[エクソソーム診断・治療のアジア太平洋市場予測2019-2027]についてメールでお問い合わせはこちら
Inkwoodリサーチが調査・発行した本調査レポートでは、エクソソーム診断・治療のアジア太平洋市場について調べ、エクソソーム診断・治療の市場動向、市場規模、セグメント別市場規模、主要企業情報などをまとめました。
*** レポート概要(サマリー)***

KEY FINDINGSThe global exosome diagnostic and therapeutic market by the Asia Pacific region is estimated to grow from $XX million in 2018 to $XX million by 2027, at a CAGR of 28.19% between 2019 and 2027.
MARKET INSIGHTS
The market for exosome diagnostic and therapeutic in APAC is mainly driven by the increase in the pervasiveness of cancer, rising government and non-government initiatives and the advancement in technology. In 2018, the diagnostic application segment accounted for the largest share of approx. XX% of the overall exosome diagnostic and therapeutic market.
Japan, China, India, Australia, South Korea, and other countries together forming the Rest of Asia Pacific regional segment are the major economies shaping up the market trends of the regional market. Asia-Pacific is a solidly packed region, with China being the most populated country. So, the country’s growth, which is supplemented by the substantially larger base of cancer patients, will increase the demand for exosome diagnostic and therapeutic products.
COMPETITIVE INSIGHTS
Hitachi Chemical Diagnostics, Inc., Qiagen N.V., System Biosciences (SBI), Malvern Instruments Ltd., Codiak BioSciences, Capricor Therapeutics, Inc., Nanosomix Inc., Sistemic Ltd., MBL International Corporation, BioCat GmbH, Thermo Fisher Scientific Inc., EVOX Therapeutics Ltd., Exosome Diagnostics Inc., HansaBioMed Life Sciences Ltd. (acquired by Lonza), and Aethlon Medical, Inc. are some of the contending market players operating that are mentioned in the report.

*** レポート目次(コンテンツ)***

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DIAGNOSTIC IS THE MAJORLY USED APPLICATION
3.2.2. SOFTWARE SEGMENT IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
3.2.3. CANCER INSTITUTES HOLD THE LARGEST MARKET SHARE IN TERMS OF END-USER
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. INCREASE IN PERVASIVENESS OF CANCER
4.2.2. RISING GOVERNMENT AND NON-GOVERNMENT INITIATIVES
4.2.3. ADVANCEMENT IN TECHNOLOGY
4.3. MARKET RESTRAINTS
4.3.1. CHALLENGES FACED IN THE USAGE OF EXOSOME
4.3.2. STRINGENT REGULATION
4.4. MARKET OPPORTUNITIES
4.4.1. LUCRATIVE GROWTH OPPORTUNITIES IN THE EMERGING ECONOMIES
4.4.2. INCREASE IN ADOPTION OF INNOVATIVE AND ADVANCED EXOSOME DIAGNOSTIC AND THERAPEUTIC PROCEDURES
4.5. MARKET CHALLENGES
4.5.1. LOW AWARENESS IN THE DEVELOPING COUNTRIES
5. MARKET BY APPLICATION
5.1. DIAGNOSTIC
5.2. THERAPEUTIC
6. MARKET BY PRODUCT
6.1. INSTRUMENT
6.2. REAGENT
6.3. SOFTWARE
7. MARKET BY END-USER
7.1. CANCER INSTITUTE
7.2. HOSPITAL
7.3. DIAGNOSTIC CENTER
7.4. OTHER END-USER
8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCES MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. THREAT OF COMPETITIVE RIVALRY
8.2. EXOSOME ETYMOLOGY
8.3. PATENT ANALYSIS
8.4. COMPONENTS OF EXOSOME
8.5. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
9.1. ASIA PACIFIC
9.1.1. JAPAN
9.1.2. CHINA
9.1.3. INDIA
9.1.4. AUSTRALIA
9.1.5. SOUTH KOREA
9.1.6. REST OF ASIA PACIFIC
10. COMPETITIVE LANDSCAPE
10.1. COMPANY PROFILES
10.1.1. AETHLON MEDICAL, INC.
10.1.2. BIOCAT GMBH
10.1.3. CAPRICOR THERAPEUTICS, INC.
10.1.4. CODIAK BIOSCIENCES
10.1.5. EVOX THERAPEUTICS LTD.
10.1.6. EXOSOME DIAGNOSTICS INC.
10.1.7. HANSABIOMED LIFE SCIENCES LTD. (ACQUIRED BY LONZA)
10.1.8. HITACHI CHEMICAL DIAGNOSTICS, INC.
10.1.9. MALVERN INSTRUMENTS LTD.
10.1.10. MBL INTERNATIONAL CORPORATION
10.1.11. NANOSOMIX INC.
10.1.12. SISTEMIC LTD.
10.1.13. SYSTEM BIOSCIENCES (SBI)
10.1.14. THERMO FISHER SCIENTIFIC INC.
10.1.15. QIAGEN N.V.

TABLE LIST
TABLE 1 NOMENCLATURE OF EXOSOME PARTICLES
TABLE 2 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC INSTRUMENT MARKET 2019-2027 ($ MILLION)
TABLE 8 COMMERCIAL KITS AND REAGENTS EXAMPLES FOR THE ISOLATION OF EXOSOME
TABLE 9 ASIA PACIFIC REAGENT MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC SOFTWARE MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC CANCER INSTITUTE MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC HOSPITAL MARKET 2019-2027 ($ MILLION)
TABLE 14 EXOSOME ASSOCIATED PROTEIN IN CLINICAL DIAGNOSTICS USAGE
TABLE 15 ASIA PACIFIC DIAGNOSTIC CENTER MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 17 TYPE OF PROTEINS FOUND IN EXOSOMES
TABLE 18 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 20 ESTIMATED MOST COMMON CANCERS DIAGNOSED IN AUSTRALIA 2017

FIGURES LIST
FIGURE 1 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY PRODUCT 2018 & 2027 (%)
FIGURE 6 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY INSTRUMENT 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REAGENT 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY SOFTWARE 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 10 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY CANCER INSTITUTE 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITAL 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC CENTER 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 14 PORTER’S FIVE FORCE MODEL
FIGURE 15 NUMBER OF PAPERS PUBLISHED ON EXOSOME 2003-2017
FIGURE 16 JAPAN EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 17 CHINA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 18 INDIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 19 AUSTRALIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 20 SOUTH KOREA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 21 REST OF ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

TABLE LIST
TABLE 1 NOMENCLATURE OF EXOSOME PARTICLES
TABLE 2 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC INSTRUMENT MARKET 2019-2027 ($ MILLION)
TABLE 8 COMMERCIAL KITS AND REAGENTS EXAMPLES FOR THE ISOLATION OF EXOSOME
TABLE 9 ASIA PACIFIC REAGENT MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC SOFTWARE MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC CANCER INSTITUTE MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC HOSPITAL MARKET 2019-2027 ($ MILLION)
TABLE 14 EXOSOME ASSOCIATED PROTEIN IN CLINICAL DIAGNOSTICS USAGE
TABLE 15 ASIA PACIFIC DIAGNOSTIC CENTER MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 17 TYPE OF PROTEINS FOUND IN EXOSOMES
TABLE 18 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 20 ESTIMATED MOST COMMON CANCERS DIAGNOSED IN AUSTRALIA 2017


FIGURES LIST
FIGURE 1 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY PRODUCT 2018 & 2027 (%)
FIGURE 6 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY INSTRUMENT 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REAGENT 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY SOFTWARE 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 10 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY CANCER INSTITUTE 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITAL 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC CENTER 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 14 PORTER’S FIVE FORCE MODEL
FIGURE 15 NUMBER OF PAPERS PUBLISHED ON EXOSOME 2003-2017
FIGURE 16 JAPAN EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 17 CHINA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 18 INDIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 19 AUSTRALIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 20 SOUTH KOREA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 21 REST OF ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)


*** 掲載企業 ***

1. AETHLON MEDICAL, INC.
2. BIOCAT GMBH
3. CAPRICOR THERAPEUTICS, INC.
4. CODIAK BIOSCIENCES
5. EVOX THERAPEUTICS LTD.
6. EXOSOME DIAGNOSTICS INC.
7. HANSABIOMED LIFE SCIENCES LTD. (ACQUIRED BY LONZA)
8. HITACHI CHEMICAL DIAGNOSTICS, INC.
9. MALVERN INSTRUMENTS LTD.
10. MBL INTERNATIONAL CORPORATION
11. NANOSOMIX INC.
12. SISTEMIC LTD.
13. SYSTEM BIOSCIENCES (SBI)
14. THERMO FISHER SCIENTIFIC INC.
15. QIAGEN N.V.


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 石油・ガスポンプの世界市場予測2018-2023
    Oil and Gas Pumps are preferred for processes that handle low viscosity liquids and high flow rates. Over the next five years, LPI(LP Information) projects that Oil and Gas Pumps will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017. In this report, …
  • ワイヤレスディスプレイの世界市場2019-2029
    • Do you need definitive Wireless Display market data?• Succinct Wireless Display market analysis? • Technological insight? • Clear competitor analysis? • Actionable business recommendations? Read on to discover how this definitive report can transform your research and save you time. The global wir …
  • 中国の水インフラ建設市場(~2019)
    This report is the result of Timetric’s extensive market research covering the water infrastructure construction industry in China. It contains detailed historic and forecast market value data for the water infrastructure construction industry, including a breakdown of the data by construction activ …
  • コスタリカの保険産業:動向と機会
    Timetric’s 'The Insurance Industry in Costa Rica, Key Trends and Opportunities to 2020' report provides in-depth market analysis, information and insights into Costa Rica insurance industry, including: • An overview of Costa Rican insurance industry • The Costa Rican insurance industry's growth pros …
  • 膨張性ポリスチレン(EPS)の世界市場予測2018-2023
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Expandable Polystyrene (EPS) market for 2018-2023. Expanded polystyrene (EPS) is a rigid and tough, closed-cell foam with a normal density range of 11 to 32 kg/m3. It is usua …
  • 塩化ヨウ素の世界市場2021
    The Global Iodinemonochloride (CAS 7790-99-0) Industry 2021 Market Research Report is a professional and in-depth study on the current state of the Iodinemonochloride industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and indu …
  • エボラウイルス感染症(Ebola Viral Infections):治療薬開発パイプライン動向2019
    SUMMARY DelveInsight’s, “ Ebola Viral Infections-Pipeline Insights, 2019”, report provides in depth insights on the pipeline drugs and their development activities around the Ebola Viral Infections. The DelveInsight’sReport covers the product profiles in various stages of development including Disco …
  • 世界の車載エンターテイメントシステム市場2017
    In-Vehicle Entertainment Systems Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Unit …
  • プラスチックペールの世界市場2020年-2030年
    Global Plastic Pails Market: Global Industry Analysis 2015-2019 & Opportunity Assessment 2020-2030 A recent market report published by Future Market Insights on the plastic pails market provides global industry analysis for 2015-2019 & forecast for 2020-2030. The report offers a comprehensive assess …
  • 整形外科用ソフトウェアの世界市場:インサイト、市場機会、市場シェア、市場予測
    The global orthopedic software market is estimated to reach $24645 million by 2022 and is expected to grow at CAGR of 6.1% during 2016-2022. The orthopedic software market is segmented on the basis of application, mode of delivery, product and geography. The application segment is segmented into ort …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(INKW906134 )"エクソソーム診断・治療のアジア太平洋市場予測2019-2027" (英文:ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027)はInkwood Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。